New combo therapy trial aims to extend lives in Tough-to-Treat cancer recurrence
Disease control
Recruiting now
This study is testing whether adding radiation and chemotherapy before immunotherapy works better than immunotherapy alone for people whose head and neck cancer has returned after initial treatment. Researchers will enroll 214 adults with recurrent cancer that cannot be surgicall…
Phase: PHASE3 • Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC